Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

RSS icon
Thumbnail

Quality intervention fails to boost outcomes for HFrEF patients

Researchers aimed to use a proven strategy to improve patient care, but their intervention did not make a substantial impact. 

Thumbnail

Increased physical activity after ICD implantation lowers the risk of death, hospitalization

Participation in cardiac rehabilitation programs remains low, the authors wrote, but this study showed that it can make a significant impact on patient outcomes. 

Thumbnail

Heart failure specialists raise $80M to ramp up work on new ventricular repair solution

The company also named the newest member of its board of directors.

healthcare value value-based care money dollar

Catheter ablation a cost-effective option for HF patients with AFib

Researchers shared their full analysis in the Journal of the American Heart Association.

Thumbnail

Cardiologists sound alarm on ongoing methamphetamine epidemic

Methamphetamine-related heart failure hospitalizations increased 585% from 2008 to 2018, researchers found. 

Empagliflozin boosts care for HFpEF patients, new clinical trial confirms

Researchers will provide a full breakdown of the study's findings in August. 

Thumbnail

Risk score predicts outcomes for heart failure patients undergoing TEER

The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period. 

A closer look at the pandemic's impact on heart attack patients

Patients presenting with an acute myocardial infarction during the start of the COVID-19 pandemic faced delays in care and a higher risk of developing heart failure.

Displaying 353 - 360 of 1270

Around the web

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Health Imaging
New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.